Filter Results
:
(86)
Show Results For
- All HBS Web (343)
- Faculty Publications (131)
Show Results For
- All HBS Web (343)
- Faculty Publications (131)
Sort by
- 01 Sep 2008
- News
In Africa, Porter Sees Lessons for Health Care
delivery systems of both developing and advanced countries: fragmentation, inefficiency, and organization around discrete interventions (such as delivering drugs or screening) rather than integrated care. Porter and his colleagues aim to...
View Details
- 16 Sep 2016
- News
Gaining Ground on ALS
president and CEO of Cytokinetics, Inc., a California-based company that focuses on biology-driven treatments for amyotrophic lateral sclerosis (ALS) and other debilitating diseases associated with muscle weakness. In 2015, the ALS...
View Details
- 01 Sep 2004
- News
Bill Dunaway (MBA 1964)
A self-described SOB — son of the boss — Bill Dunaway grew up working in his father’s pharmacy in Marietta, Georgia, a town of 61,000 outside Atlanta. After expanding the business to a chain of 18 drug stores, Dunaway sold the operation...
View Details
- 25 Apr 2014
- News
A revolution in healing
Stéphane Bancel (MBA 2000) is president and CEO of Moderna Therapeutics, which is producing a new drug application that could revolutionize the biotech world. It hinges on messenger RNA, or mRNA, the molecules responsible for transporting...
View Details
- 01 Sep 2004
- News
A Market-Based Prescription
and nephrologist. In a focused factory, all these resources are integrated. These diabetic specialists jointly develop treatment protocols and pricing. Together, they offer a full range of services customized for this disease. Research...
View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
Cytokinetics, Inc., a South San Francisco–based company that focuses on treatments for debilitating diseases that compromise muscle function, such as amyotrophic lateral sclerosis (ALS), heart failure, and spinal muscular atrophy....
View Details
Keywords:
Deborah Blagg
- 01 Jun 2018
- News
Floor It
The sci-fi future for cancer treatment has become a reality, with breakthrough therapies that can use a cancer patient’s genetic information to create personalized treatments or employ the body’s immune...
View Details
Keywords:
Julia Hanna; illustration by Mengxin Li
- 01 Dec 2017
- News
2017 in Health Care: Telemedicine Has Arrived
telemedicine services available next year to employees in states that allow it. We’re going to see a lot more investment in this area, from both established health care companies and startups. What’s next in health care? “More constraints on View Details
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
networking among its alumni community. Bowes, founding partner of US Venture Partners, and Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), discussed the need for innovative, results-oriented biomedical research and View Details
- 01 Jun 2012
- News
The Power of Philanthropy
announced its approval of Kalydeco, a drug produced by Vertex that will immediately help some 1,200 cystic fibrosis patients and is viewed as a breakthrough precursor drug to forthcoming products that will...
View Details
- 02 Aug 2018
- News
Can Marketing Help Halt the Heroin Epidemic?
Subscribe on iTunes Subscribe on SoundCloud More Skydeck episodes Dan Morrell: In 2008, Jim Langford (MBA 1984) became the executive director of the Georgia Meth Project, a nonprofit that blanketed his native state with a graphic, disturbing ad campaign dedicated to...
View Details
- 01 Jun 2000
- News
The Business of Biotech
December). Amgen's Epogen (a treatment for anemia in kidney dialysis patients) and Neupogen (which restores white blood cells in cancer patients) generated more than $2 billion in sales last year. As the ability to analyze a patient's...
View Details
Keywords:
Julia Hanna
- 14 May 2014
- News
(Re)moving the Needle
You wouldn't think that the lowly, annoying mosquito would have anything to teach researchers working on the cutting edge of drug delivery methodology, but you would be wrong. Have you ever noticed that you don't become aware of a...
View Details
- 01 Mar 2010
- News
Noted & Quoted
“Unfortunately, the technology for growing flu viruses to make vaccines is fifty years old — it’s chicken eggs.” — HBS Professor of Management Practice and former Merck CEO Raymond Gilmartin, at a November HBS panel discussion on drug...
View Details
- 01 Mar 2008
- News
The Last Frontier
state for people with debilitating but nonterminal diseases like his to receive, with a doctor’s assistance, drugs with which they may take their own lives. Explained Gardner, “Why do this? I want to be involved in public life. I was...
View Details
- 24 Apr 2014
- News
Finding a cure so that others may benefit
call. The foundation wanted to invest in for-profit bioscience companies to spur scientists to find a cure for the disease. O’Donnell is credited with almost singlehandedly raising $250 million in support of this venture philanthropy, which led to the development of...
View Details
- 01 Dec 2004
- News
Finding a Balance
Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical company that manufactures and sells...
View Details
- 01 Sep 2006
- News
Redefining Health Care
high costs understandable. What Wennberg and others did was to show that U.S. health care also has severe quality problems. Indeed, there is every possible quality problem you can imagine: incorrect diagnoses, drug errors, unnecessary...
View Details
- 05 May 2020
- News
“Walking a Tightrope”
is going to be transmitted yet again to the next generation. A year and a half, two years ago now, we ran into Drew. He was in a drug treatment program called Provoking Hope based in McMinnville, Oregon....
View Details
- 01 Dec 2002
- News
Alumni Honorees Urge Students to Emphasize Ethics
2002 Alumni Achievement Awards Raymond V. Gilmartin (MBA '68) Chairman, President, and CEO, Merck & Co. Since June 1994, when Gilmartin became its president and CEO, Merck has launched seventeen new drugs and increased revenues from $15...
View Details